Dec. 2015: CVS Health (Stock to Study), Chrevon (Undervalued)

The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corporation (NYSE: CVS) as its December 2015 "Stock to Study" and Chevron Corporation (NYSE: CVX) as its December 2015 "Undervalued Stock" for investors' informational and educational use.

"The committee selected CVS for its solid, steady growth and ability to diversify into other health care industries," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee cited Chevron's current yield, which is in the 6% range." Check BetterInvesting's December issue for more details about these selections.

Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.

As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.
Sample Our Resources Open House Get Your Resources